A pathogenic variant in hereditary breast and ovarian cancer (HBOC) predisposing BRCA1 and BRCA2 genes is present in 3–5% of breast cancer cases and 10% of ovarian cancer cases [5]. Here, BRCA1 is linked to ovarian carcinoma.